Cenikor

Webinar: Medication-Assisted Treatment for Opioid Use Recovery
2024-10-08 11:00 - 12:30 (America/Chicago) | San Antonio Country Club, 4100 N. New Braunfels Ave, San Antonio, TX, 78209, United States
There is little doubt that medication-assisted treatment (MAT) approaches are effective in for SUD in general, and opioid use disorder (OUD) in particular. But the evidence-based, MAT utilization lags. Did you know: any clinician with a current DEA registration that includes Schedule III authority can now prescribe buprenorphine, the most effective, FDA-approved treatment for opioid use disorder? And the maximum number of consumers with substance use disorder (SUD) who can be treated by a provider has increased. However, a year after the changes in regulation to expand access to life-saving medications, there has not been a meaningful increase in buprenorphine use.

Join Cenikor’s Regional Medical Director, Dr. Eric Ketcham, and Cenikor’s Assistant Vice President of Marketing and Business Development, Sara Buckler, to learn more about MAT.

CMEs are available for physicians.
